These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Rheumatic disease associations with HLA antigens. Milazzo SC Aust N Z J Med; 1978; 8 Suppl 1():30-2. PubMed ID: 310296 [No Abstract] [Full Text] [Related]
25. [Antinuclear antibodies and beta1A concentration in systemic lupus erythematosus and other diseases]. Monegat JN; Joller-Jemelka HI; Grob PJ Schweiz Med Wochenschr; 1974 Nov; 104(45):1614-23. PubMed ID: 4612703 [No Abstract] [Full Text] [Related]
26. Laboratory diagnosis and monitoring of rheumatologic diseases. Percy JS; Russell AS Can Med Assoc J; 1975 Jun; 112(11):1320-8. PubMed ID: 236088 [TBL] [Abstract][Full Text] [Related]
27. [Immunohistochemical research in diffuse reactive mesenchymopathies. Results and interpretative speculations]. Grimaldi MG Recenti Prog Med; 1969 Feb; 46(2):133-69. PubMed ID: 4893918 [No Abstract] [Full Text] [Related]
28. Quantitative studies of immunofluorescent staining. VI. Defined complement immunofluorescent staining for antinuclear antibodies in systemic lupus and other collagen diseases. Diaz Gill GA; Beutner EH; Eisenberg RB Int Arch Allergy Appl Immunol; 1973; 45(6):868-79. PubMed ID: 4586867 [No Abstract] [Full Text] [Related]
29. Antinuclear factor in rheumatoid arthritis and related diseases. Pitkeathly DA; Taylor G Ann Rheum Dis; 1967 Jan; 26(1):1-9. PubMed ID: 4163368 [No Abstract] [Full Text] [Related]
30. [Titers of C 3 factor of serum complement in various autoimmune diseases]. Lehman C; Andreis M; Bennett L; Godoy G Rev Med Chil; 1972; 100(5):497-501. PubMed ID: 4625016 [No Abstract] [Full Text] [Related]
31. [Comparative studies of the demonstration of antinuclear factors by immunofluorescence and antiglobulin consumption tests]. Schmidt K; Mueller-Eckhardt C; Becker W Verh Dtsch Ges Rheumatol; 1969; 1():251-8. PubMed ID: 4934585 [No Abstract] [Full Text] [Related]
32. [Pathomechanisms of tissue damage exemplified by collagenoses]. Kalden JR; Krapf F Verh Dtsch Ges Inn Med; 1987; 93():93-7. PubMed ID: 3502054 [No Abstract] [Full Text] [Related]
34. Rheumatoid arthritis and systemic lupus erythematosus (SLE). Beer TC; Gumpel JM Proc R Soc Med; 1973 Sep; 66(9):910. PubMed ID: 4141773 [No Abstract] [Full Text] [Related]
35. [Chief directions in the area of nucleic acid metabolism research in collegenoses]. Zborovskii AB; Chernyshov EP Vopr Revm; 1972; 12(3):66-73. PubMed ID: 4124311 [No Abstract] [Full Text] [Related]
36. Studies on synovial fluid in arthritis. I. The total complement activity. II. The occurrence of mononuclear cells with in vitro cytotoxic effect. Hedberg H Acta Med Scand Suppl; 1967; 479():1-137. PubMed ID: 4172267 [No Abstract] [Full Text] [Related]
37. [Serum complement and synovial complement. Respective variations in rheumatic pathology]. Kourilsky O; Peltier AP; de Sèze S Nouv Presse Med; 1972 Jun; 1(26):1769-76. PubMed ID: 4538278 [No Abstract] [Full Text] [Related]
38. [Incidence of adenovirus antibodies in patients with various clinical forms of chronic rheumatism]. Athanasiu P; Broniţki A; Moisa I Stud Cercet Inframicrobiol; 1969; 20(3):179-83. PubMed ID: 4310663 [No Abstract] [Full Text] [Related]
39. [The 3d component of complement (B1A globulin) in collagenoses and its diagnostic significance]. Popov PN; Speranskiĭ AI; Nasonova VA Ter Arkh; 1974; 46(3):50-7. PubMed ID: 4133373 [No Abstract] [Full Text] [Related]